Trinity Biotech (TRIB) Divestments (2010 - 2023)
Trinity Biotech (TRIB) posted quarterly Divestments of -$266000.0 for Q3 2023, down 100.57% on a QoQ basis from $46.8 million in Q4 2010.
Trinity Biotech (TRIB) Divestments (2010 - 2023) Analysis & Trends
Trinity Biotech (TRIB) has reported Divestments for 2 consecutive years, with -$266000.0 the latest figure, recorded in Q3 2023.
- Quarterly Divestments changed N/A year-over-year to -$266000.0 in Q3 2023, while the trailing twelve-month figure through Dec 2010 was $46.8 million (changed N/A YoY) and the FY2023 annual result came in at $28.2 million, changed N/A from the prior year.
- Divestments eased to -$266000.0 in Q3 2023 per TRIB's latest filing, from $46.8 million in the prior quarter.
- Over the last five years, Divestments for TRIB reached as high as -$266000.0 in Q3 2023 and fell as low as -$266000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.37 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -266,000.00 |
| Dec 31, 2010 | 46.78 Mn |